Literature DB >> 2234207

Survival and mortality in a randomized study of lung cancer detection.

A Kubík1, J Haerting.   

Abstract

In a randomized prospective study of lung cancer detection in a high-risk population of over 6000 heavy smokers semiannual screening by X-ray and sputum cytology was compared to screening at a 3-year interval. The comparison of Kaplan-Meier estimates of survival curves done without and with correcting for lead-time bias disclosed a rather important impact of lead-time bias on survival comparisons. On the contrary, controlling for possible length bias had no obvious effect on the shape of survival curves. The evaluation of mortality from lung cancer, being used as a basic criterion, indicated no traceable benefit from semiannual screening. The higher incidence of lung cancer in the frequently screened group was paralleled by a higher mortality. It is concluded that currently available screening techniques will not solve the problem of lung cancer mortality in smokers. The results underline the importance of primary prevention for lung cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2234207

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  3 in total

Review 1.  Screening for lung cancer.

Authors:  Renée Manser; Anne Lethaby; Louis B Irving; Christine Stone; Graham Byrnes; Michael J Abramson; Don Campbell
Journal:  Cochrane Database Syst Rev       Date:  2013-06-21

2.  Improvement of survival for non-small cell lung cancer over time.

Authors:  Wenjie Xia; Xinnian Yu; Qixing Mao; Wenying Xia; Anpeng Wang; Gaochao Dong; Bing Chen; Weidong Ma; Lin Xu; Feng Jiang
Journal:  Onco Targets Ther       Date:  2017-08-29       Impact factor: 4.147

3.  Do we know enough about the effect of low-dose computed tomography screening for lung cancer on survival to act? A systematic review, meta-analysis and network meta-analysis of randomised controlled trials.

Authors:  Huiqin Yang; Jo Varley-Campbell; Helen Coelho; Linda Long; Sophie Robinson; Tristan Snowsill; Ed Griffin; Jaime Peters; Chris Hyde
Journal:  Diagn Progn Res       Date:  2019-11-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.